# Exploratory Study Evaluating the Effects of Darifenacin on Nocturia, Sleep and Daytime Wakefulness

> **NCT01018225** · PHASE4 · WITHDRAWN · sponsor: **Cognitive Research Corporation**

## Conditions studied

- Nocturia

## Interventions

- **DRUG:** darifenacin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01018225
- **Lead sponsor:** Cognitive Research Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-11
- **Primary completion:** —
- **Final completion:** 2010-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was cancelled due to lack of enrollment
- **Last updated:** 2016-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01018225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01018225, "Exploratory Study Evaluating the Effects of Darifenacin on Nocturia, Sleep and Daytime Wakefulness". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01018225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*